Blenheim Pharmacal recalls
Blenheim Pharmacal has 2 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 3 Jun 2015. The most frequent reason is manufacturing (cgmp) deviations.
Total recalls2since 2015
Last 12 months0reported
Class I00% of total
Ongoing0latest 3 Jun 2015
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 2 100%Class III 0 0%
Why blenheim pharmacal is recalled
By year
All blenheim pharmacal recalls, newest first
2 total| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Clarithromycin Tablets, USP, 500 mg recalled by Blenheim Pharmacal | Blenheim Pharmacal | Manufacturing (CGMP) Deviations | IN |
| Drug | CLASS II | Captopril Tablets, USP, 50 mg recalled by Blenheim Pharmacal | Blenheim Pharmacal | Manufacturing (CGMP) Deviations | IN |
About this list
Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.